JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

NCT06751485 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal
Fallopian Tube Cancers

Interventions

DRUG: JSKN003
DRUG: Doxorubicin
DRUG: Paclitaxel
DRUG: Topotecan

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd